BANGALORE/WASHINGTON (Reuters) – Tech services giant Infosys Ltd (INFY.NS: Quote, Profile, Research, Stock Buzz) agreed on Wednesday to pay $34 million to end a U.S. investigation related to the widespread practice by Indian firms of flying workers to client sites in the United States on temporary visas.
The settlement, which the U.S. Justice Department said was the largest in a case of alleged civil fraud over visas, was filed in U.S. District Court for the Eastern District of Texas.
WASHINGTON (Reuters) – The new FBI chief on Monday ordered all new agents and analysts to visit the national memorial to late civil rights leader Martin Luther King Jr. as a reminder not to repeat the abuses of the U.S. investigative bureau’s past.
In a similar gesture in 2000, the FBI added a stop at the U.S. Holocaust Memorial Museum to its required training for new agents. Both sites, along with FBI headquarters, are in Washington.
WASHINGTON (Reuters) – Foes of President Barack Obama’s healthcare law lost a bid on Tuesday to put an immediate stop to a key part of the law – the insurance subsidies in the 34 U.S. states that declined to establish their own online marketplaces.
At a court hearing, U.S. District Judge Paul Friedman in Washington, D.C., declined to grant a preliminary injunction sought by a group of individuals and small businesses that in a lawsuit call the subsidies unlawful.
WASHINGTON (Reuters) – The U.S. Supreme Court said on Monday it would hear a death row appeal from a Florida man ruled mentally disabled in 1992 but later found competent to be executed after he scored 71 on an IQ test, the minimum under state law.
In a brief order, the court said it would consider whether Florida used a lawful process to determine that convicted murderer Freddie Lee Hall, awaiting execution pending appeals, was not mentally disabled after all.
WASHINGTON (Reuters) – The U.S. Supreme Court on Monday declined to consider whether a unit of Thomson Reuters Corp can obtain and sell information on drivers provided by state agencies without violating a federal privacy law.
The decision not to hear the matter represented a win for the commercialization of publicly available information, although U.S. law remains mixed on the subject.
WASHINGTON, Oct 21 (Reuters) – The U.S. Supreme Court on
Monday asked the Obama administration to weigh in on a case that
raises whether bank secrecy laws protect Arab Bank Plc
from turning over documents in lawsuits in U.S. courts.
The high court, which is considering whether to hear the
case, made the request to the Justice Department’s Office of the
WASHINGTON (Reuters) – A U.S. appeals court showed a potential willingness on Friday to intervene in the forced feeding of Guantanamo Bay hunger strikers, which the Obama administration says is necessary to keep order but that critics call inhumane.
At a hearing of the U.S. Court of Appeals for the District of Columbia Circuit, two judges on a three-judge panel asked skeptical questions of a government lawyer who argued that the court had no jurisdiction at a military prison such as the U.S. Navy base in Cuba.
WASHINGTON (Reuters) – The United States brought new manslaughter charges on Thursday against four former Blackwater Worldwide security guards for a 2007 shooting in Baghdad that prosecutors said killed 14 unarmed civilians.
The shooting caused tension in U.S.-Iraqi relations and raised concerns about the U.S. government’s use of private contractors, who were shielded from prosecution in Iraq.
WASHINGTON (Reuters) – Boston Scientific Corp (BSX.N: Quote, Profile, Research, Stock Buzz) agreed to pay $30 million to settle allegations that the Guidant unit it acquired in 2006 knowingly sold defective heart devices implanted in Medicare patients, the U.S. Justice Department said on Thursday.
Guidant from 2002 to 2005 sold the implantable defibrillators even though it knew they could short-circuit and become ineffective at correcting heartbeat rhythms, the department said in a statement.
WASHINGTON, Oct 17 (Reuters) – Boston Scientific Corp
agreed to pay $30 million to settle allegations that the
Guidant unit it acquired in 2006 knowingly sold defective heart
devices implanted in Medicare patients, the U.S. Justice
Department said on Thursday.
Guidant from 2002 to 2005 sold the implantable
defibrillators even though it knew they could short-circuit and
become ineffective at correcting heartbeat rhythms, the
department said in a statement.